Reccan Diagnostics successfully raises SEK 15M in a new share issue

Company news
Written By Anna Brodén

Reccan Diagnostics, a spin-off company from Lunds universitet, raises 15 MSEK in a share issues from new and current shareholders. Investors include Cardeon Futuring Finance AB, Tibia Konsult AB, Jan Hain and Christer Fåhraeus.

Anna Brodén
Previous

Reccan raises 14 MSEK from mainly current owners
Next

Sten K Johnson Foundation award “Development of a predictive and stratifying biomarker panel in pancreatic cancer tissue”